cbdMD, Inc.
YCBD
$0.49
-$0.01-1.56%
AMEX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -1.53% | 12.42% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.53% | 12.42% | |||
| Cost of Revenue | 5.59% | 18.23% | |||
| Gross Profit | -6.74% | 8.52% | |||
| SG&A Expenses | 2.17% | 26.43% | |||
| Depreciation & Amortization | 2.94% | 2.53% | |||
| Other Operating Expenses | 41.43% | -31.04% | |||
| Total Operating Expenses | 3.78% | 21.45% | |||
| Operating Income | -41.17% | -179.71% | |||
| Income Before Tax | -41.25% | -181.88% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -41.25% | -181.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -41.25% | -181.88% | |||
| EBIT | -41.17% | -179.71% | |||
| EBITDA | -58.69% | -1,246.08% | |||
| EPS Basic | -34.40% | -132.69% | |||
| Normalized Basic EPS | -38.91% | -142.64% | |||
| EPS Diluted | -34.40% | -132.69% | |||
| Normalized Diluted EPS | -38.91% | -142.64% | |||
| Average Basic Shares Outstanding | 1.66% | 15.99% | |||
| Average Diluted Shares Outstanding | 1.66% | 15.99% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||